Genocea Biosciences

(NASDAQ: GNCA)
Healthcare  |  Biotechnology
3.69 0.07 1.93%
Stock Price | July 18, 2019, 3:59 p.m.
0 Followers
Bid: 3.25
Ask: 4.0
Prev. Close: 3.62
52 Week Low: 2.24
52 Week High: 11.28
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.

Read more Read less

Recently Viewed Tickers

Premium Stock Watchlist 12/17/2015

3 years ago

Premium Stock Watchlist 11/04/2015

3 years ago

Premium Stock Watchlist 10/30/2015

3 years ago

Premium Stock Watchlist 10/29/2015

3 years ago